Component

Human stem-cell-derived SLC30A8-null beta cells

Human stem-cell-derived SLC30A8-null beta cells

3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. After 5 micromolar TPEN for 48 hours, apoptosis was lower in SLC30A8-null and R138X cells than treated wild-type cells.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    curation_topic
    zinc · Zinc
    experimental_condition
    Wild-type cells with the same TPEN exposure Limited availability during TPEN exposure · Zinc Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_condition
    Wild-type cells with the same TPEN exposure Null genotype; R138X tested separately · Human zinc transporter ZnT8 / SLC30A8 Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_contrast
    {"intervention": "ZnT8 loss plus TPEN", "comparator": "Wild-type cells with the same TPEN exposure", "endpoint": "TUNEL-positive beta cells", "effect_direction": "decrease", "combination": "joint", "conditions": [{"entity_slug": "slc30a8", "state": "Null genotype; R138X tested separately"}, {"entity_slug": "zinc", "state": "Limited availability during TPEN exposure"}]} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed
    limitations
    Chelator challenge, not dietary restriction; human in-vivo protection by this mechanism remains untested.
    primary_references
    SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Diabetes cascade: targeted primary-source supplement · lines 15–15

    See claim-local references; curated paraphrases reviewed 2026-09-20. · supports · Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed · source_derived_draft · unverified_draft

    After 5 micromolar TPEN for 48 hours, apoptosis was lower in SLC30A8-null and R138X cells than treated wild-type cells. Model: Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed. Limits: Chelator challenge, not dietary restriction; human in-vivo protection by this mechanism remains untested. Primary reference: SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
    Complete structured claim and evidence
  2. SLC30A8 knockout elevated free cytosolic zinc, whereas R138X did not show the same significant elevation.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    curation_topic
    zinc · Zinc
    experimental_condition
    Wild-type cells SLC30A8 knockout · Human stem-cell-derived SLC30A8-null beta cells Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_contrast
    {"intervention": "SLC30A8 knockout", "comparator": "Wild-type cells", "endpoint": "Cytosolic free zinc", "effect_direction": "increase", "combination": "single", "conditions": [{"entity_slug": "human-slc30a8-null-beta-cells", "state": "SLC30A8 knockout"}]} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed
    limitations
    Compartment-specific sensor measurement; not total-body zinc.
    primary_references
    SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Diabetes cascade: targeted primary-source supplement · lines 9–9

    See claim-local references; curated paraphrases reviewed 2026-09-20. · supports · Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed · source_derived_draft · unverified_draft

    SLC30A8 knockout elevated free cytosolic zinc, whereas R138X did not show the same significant elevation. Model: Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed. Limits: Compartment-specific sensor measurement; not total-body zinc. Primary reference: SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
    Complete structured claim and evidence
  3. SLC30A8-null and R138X beta cells had fewer crystalline insulin granules; glucose-stimulated secretion was not impaired in the tested system.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    curation_topic
    zinc · Zinc
    experimental_condition
    Wild-type cells SLC30A8-null or R138X cells · Human stem-cell-derived SLC30A8-null beta cells Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_contrast
    {"intervention": "SLC30A8-null or R138X cells", "comparator": "Wild-type cells", "endpoint": "Granule crystallization", "effect_direction": "decrease", "combination": "single", "conditions": [{"entity_slug": "human-slc30a8-null-beta-cells", "state": "SLC30A8-null or R138X cells"}]} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed
    limitations
    Separate genotypes, not a combined knockout. Preserved secretion does not establish universal protection.
    primary_references
    SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Diabetes cascade: targeted primary-source supplement · lines 12–12

    See claim-local references; curated paraphrases reviewed 2026-09-20. · supports · Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed · source_derived_draft · unverified_draft

    SLC30A8-null and R138X beta cells had fewer crystalline insulin granules; glucose-stimulated secretion was not impaired in the tested system. Model: Engineered human embryonic stem-cell-derived beta cells; results and figure 5 reviewed. Limits: Separate genotypes, not a combined knockout. Preserved secretion does not establish universal protection. Primary reference: SLC30A8 stem-cell study; 2023; PMCID:PMC10047077; https://pmc.ncbi.nlm.nih.gov/articles/PMC10047077/
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards